ANGELIA MICKLE: Open Payments
NPI 1790117141 · JAMESTOWN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,377 in 64 payments from 11 companies in 2025. Trend: 2023 $6,960 · 2024 $8,537 · 2025 $4,377
Speaker / faculty: $3,000Food & beverage: $1,273Travel & lodging: $104
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $3,397 |
| E.R. Squibb & Sons, L.L.C. | 8 | $303 |
| Neurocrine BioSciences, Inc. | 13 | $261 |
| Otsuka America Pharmaceutical, Inc. | 10 | $150 |
| Alkermes, Inc. | 3 | $72 |
| Teva Pharmaceuticals USA, Inc. | 3 | $53 |
| Axsome Therapeutics, Inc. | 2 | $46 |
| Janssen Pharmaceuticals, Inc | 2 | $36 |
| Lundbeck LLC | 1 | $27 |
| Luye Pharma (USA) Ltd. | 1 | $17 |
Products named: VRAYLAR, COBENFY, INGREZZA, ARISTADA, ABILIFY MAINTENA, REXULTI, ABILIFY ASIMTUFII, Auvelity.
Industry payments across OH — which companies pay providers there.
